SHE:000403 Revenue

Pacific Shuanglin Bio-pharmacy Co., LTD had revenue of 374.65M CNY in the quarter ending March 31, 2025, a decrease of -14.00%. This brings the company's revenue in the last twelve months to 2.59B, up 3.60% year-over-year. In the year 2024, Pacific Shuanglin Bio-pharmacy Co., LTD had annual revenue of 2.65B with 14.00% growth.

Revenue (ttm)

2.59B

Revenue Growth

+3.60%

P/S Ratio

6.15

Revenue / Employee

984.32K

Employees

2,635

Market Cap

15.95B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.65B	325.96M	14.00%
Dec 31, 2023	2.33B	-76.47M	-3.18%
Jan 1, 2023	2.41B	433.45M	21.98%
Jan 1, 2022	1.97B	921.80M	87.80%
Jan 1, 2021	1.05B	134.28M	14.67%
Jan 1, 2020	Pro	Pro	Pro
Jan 1, 2019	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings